Inovio Pharmaceuticals - 28 Year Stock Price History | INO

Historical daily share price chart and data for Inovio Pharmaceuticals since 1998 adjusted for splits and dividends. The latest closing stock price for Inovio Pharmaceuticals as of February 06, 2026 is 1.66.
  • The all-time high Inovio Pharmaceuticals stock closing price was 2283.80 on March 03, 2000.
  • The Inovio Pharmaceuticals 52-week high stock price is 2.98, which is 79.5% above the current share price.
  • The Inovio Pharmaceuticals 52-week low stock price is 1.30, which is 21.7% below the current share price.
  • The average Inovio Pharmaceuticals stock price for the last 52 weeks is 1.97.
Inovio Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2026 1.5912 1.6900 1.7000 1.5100 1.6600 -4.60%
2025 2.0109 1.8200 2.8700 1.3100 1.7400 -4.92%
2024 7.9385 6.7200 13.8800 1.7800 1.8300 -70.10%
2023 8.8627 18.2400 22.9200 4.2000 6.1200 -67.31%
2022 30.3050 62.4000 62.4000 16.9200 18.7200 -68.74%
2021 101.6790 116.7600 203.5200 59.8800 59.8800 -43.62%
2020 141.5198 38.5200 380.2800 35.7600 106.2000 168.18%
2019 37.4971 50.6400 61.2000 23.6400 39.6000 -17.50%
2018 56.4406 56.1600 73.3200 46.5600 48.0000 -3.15%
2017 75.2006 84.5365 103.7870 49.5600 49.5600 -40.28%
2016 99.8477 76.5252 136.1910 58.8288 82.9821 3.27%
2015 92.1795 111.4400 126.7450 67.5574 80.3515 -26.80%
2014 126.4740 137.2670 182.7040 95.6566 109.7660 -20.86%
2013 61.5523 23.9141 143.4850 23.9141 138.7020 480.00%
2012 26.3457 21.0444 35.3929 19.1313 23.9141 16.28%
2011 39.2818 56.4374 72.6990 17.6965 20.5662 -62.61%
2010 56.0844 52.6111 71.2641 37.3061 55.0025 0.88%
2009 47.3462 24.8707 152.0940 13.3919 54.5242 119.23%
2008 38.7258 44.9586 69.3510 7.6525 24.8707 -43.48%
2007 117.0688 157.3550 199.4440 40.6540 44.0020 -72.04%
2006 124.0696 117.1790 171.7040 95.6566 157.3550 44.93%
2005 149.8031 186.5300 239.6200 95.1783 108.5700 -42.39%
2004 230.6424 265.9250 363.4950 119.5710 188.4430 -21.20%
2003 129.7057 53.5677 264.0120 45.9151 239.1410 362.96%
2002 79.3114 124.3540 162.6160 26.7838 51.6545 -57.81%
2001 176.7891 179.3560 325.2320 72.6990 122.4400 -31.73%
2000 639.3830 645.6820 2283.8000 143.4850 179.3560 -71.15%
1999 612.2660 657.6390 777.2090 442.4120 621.7680 -1.89%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.111B $0.000B
Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio's clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company's partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $299.372B 21.12
Amgen (AMGN) United States $206.949B 17.59
Gilead Sciences (GILD) United States $189.204B 18.62
Bristol Myers Squibb (BMY) United States $126.196B 10.08
GSK (GSK) United Kingdom $122.773B 13.33
Vertex Pharmaceuticals (VRTX) United States $121.257B 31.22
Regeneron Pharmaceuticals (REGN) United States $82.556B 21.77
CSL (CSLLY) Australia $62.313B 0.00
Argenex SE (ARGX) Netherlands $50.215B 62.04
Alnylam Pharmaceuticals (ALNY) United States $43.355B 1426.78
Insmed (INSM) United States $31.961B 0.00
Biogen (BIIB) United States $29.514B 13.16
Royalty Pharma (RPRX) United States $25.774B 9.88
BioNTech SE (BNTX) Germany $24.009B 0.00
Incyte (INCY) United States $21.279B 20.37
Genmab (GMAB) Denmark $19.850B 14.93
Exact Sciences (EXAS) United States $19.688B 543.05
Revolution Medicines (RVMD) United States $18.847B 0.00
Illumina (ILMN) United States $18.293B 24.68
Roivant Sciences (ROIV) United Kingdom $17.958B 0.00
Moderna (MRNA) United States $16.024B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $14.594B 0.00
Ascendis Pharma (ASND) Denmark $13.768B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $13.465B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $13.172B 21.26
Guardant Health (GH) United States $12.837B 0.00
Exelixis (EXEL) United States $11.770B 18.84
Avidity Biosciences (RNA) United States $11.281B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.168B 20.25
QIAGEN (QGEN) Netherlands $10.759B 20.61
Bio-Techne Corp (TECH) United States $10.448B 37.94
Jazz Pharmaceuticals (JAZZ) Ireland $10.057B 39.22
Halozyme Therapeutics (HALO) United States $9.552B 15.27
Abivax SA (ABVX) France $9.231B 0.00
Axsome Therapeutics (AXSM) United States $9.203B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $9.034B 42.17
Praxis Precision Medicines (PRAX) United States $8.052B 0.00
Repligen (RGEN) United States $8.003B 85.65
Bio-Rad Laboratories (BIO.B) United States $7.959B 28.62
Krystal Biotech (KRYS) United States $7.909B 40.89
Cytokinetics (CYTK) United States $7.622B 0.00
Nuvalent (NUVL) United States $7.532B 0.00
Vaxcyte (PCVX) United States $7.350B 0.00
Belite Bio (BLTE) United States $7.048B 0.00
Cidara Therapeutics (CDTX) United States $6.960B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.915B 0.00
Merus (MRUS) Netherlands $6.826B 0.00
PTC Therapeutics (PTCT) United States $5.996B 8.14
ImmunityBio (IBRX) United States $5.959B 0.00
Alkermes (ALKS) Ireland $5.764B 16.95
Kymera Therapeutics (KYMR) United States $5.726B 0.00
Protagonist Therapeutics (PTGX) United States $5.282B 136.27
Cogent Biosciences (COGT) United States $5.279B 0.00
Mirum Pharmaceuticals (MIRM) United States $5.164B 0.00
Celcuity (CELC) United States $4.939B 0.00
Scholar Rock Holding (SRRK) United States $4.858B 0.00
Immunovant (IMVT) United States $4.741B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.645B 0.00
TG Therapeutics (TGTX) United States $4.582B 10.38
Zealand Pharma (ZLDPF) Denmark $4.551B 4.61
Structure Therapeutics (GPCR) United States $4.546B 0.00
Akero Therapeutics (AKRO) United States $4.499B 0.00
Amicus Therapeutics (FOLD) United States $4.486B 357.50
Apogee Therapeutics (APGE) United States $4.252B 0.00
CG Oncology (CGON) United States $4.062B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.986B 33.66
Arcellx (ACLX) United States $3.934B 0.00
ADMA Biologics Inc (ADMA) United States $3.910B 27.85
GRAIL (GRAL) United States $3.901B 0.00
Erasca (ERAS) United States $3.805B 0.00
Ligand Pharmaceuticals (LGND) United States $3.748B 92.00
Liquidia (LQDA) United States $3.744B 0.00
Anbio Biotechnology (NNNN) Germany $3.691B 0.00
Terns Pharmaceuticals (TERN) United States $3.402B 0.00
Arcutis Biotherapeutics (ARQT) United States $3.346B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.266B 95.76
Viking Therapeutics (VKTX) United States $3.215B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.198B 0.00
Legend Biotech (LEGN) United States $3.158B 0.00
Denali Therapeutics (DNLI) United States $3.092B 0.00
Edgewise Therapeutics (EWTX) United States $3.081B 0.00
Twist Bioscience (TWST) United States $3.019B 0.00
Disc Medicine (IRON) United States $3.009B 0.00
Apellis Pharmaceuticals (APLS) United States $2.972B 75.77
IDEAYA Biosciences (IDYA) United States $2.820B 0.00
Viridian Therapeutics (VRDN) United States $2.792B 0.00
Vera Therapeutics (VERA) United States $2.781B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.743B 0.00
Alumis (ALMS) United States $2.734B 0.00
Spyre Therapeutics (SYRE) United States $2.725B 0.00
Beam Therapeutics (BEAM) United States $2.691B 0.00
Travere Therapeutics (TVTX) United States $2.658B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.648B 0.00
Bavarian Nordic (BVNRY) Denmark $2.409B 6.54
Adaptive Biotechnologies (ADPT) United States $2.408B 0.00
Telix Pharmaceuticals (TLX) Australia $2.405B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.383B 0.00
Mineralys Therapeutics (MLYS) United States $2.356B 0.00
Ascentage Pharma Group - (AAPG) China $2.288B 0.00
Immunome (IMNM) United States $2.282B 0.00
Arcus Biosciences (RCUS) United States $2.271B 0.00
WAVE Life Sciences (WVE) Singapore $2.249B 0.00
Dianthus Therapeutics (DNTH) United States $2.194B 0.00
Maze Therapeutics (MAZE) United States $2.167B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.147B 11.72
Recursion Pharmaceuticals (RXRX) United States $2.069B 0.00
Mesoblast (MESO) Australia $2.058B 0.00
Zai Lab (ZLAB) China $2.015B 0.00
Nuvation Bio (NUVB) United States $1.954B 0.00
Sarepta Therapeutics (SRPT) United States $1.939B 0.00
Stoke Therapeutics (STOK) United States $1.851B 48.36
ANI Pharmaceuticals (ANIP) United States $1.839B 14.26
Vericel (VCEL) United States $1.830B 150.79
Syndax Pharmaceuticals (SNDX) United States $1.826B 0.00
Dynavax Technologies (DVAX) United States $1.820B 53.45
MannKind (MNKD) United States $1.775B 57.80
Olema Pharmaceuticals (OLMA) United States $1.741B 0.00
Corvus Pharmaceuticals (CRVS) United States $1.714B 0.00
Zymeworks (ZYME) United States $1.700B 0.00
MBX Biosciences (MBX) United States $1.691B 0.00
Tango Therapeutics (TNGX) United States $1.685B 0.00
Tyra Biosciences (TYRA) United States $1.655B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.616B 0.00
Sionna Therapeutics (SION) United States $1.612B 0.00
Rapt Therapeutics (RAPT) United States $1.599B 0.00
UniQure (QURE) Netherlands $1.598B 0.00
Celldex Therapeutics (CLDX) United States $1.579B 0.00
Agios Pharmaceuticals (AGIO) United States $1.547B 0.00
Alvotech (ALVO) Luxembourg $1.544B 22.26
Precigen (PGEN) United States $1.518B 0.00
Oculis Holding AG (OCS) Switzerland $1.492B 0.00
Mind Medicine (MindMed) (MNMD) United States $1.480B 0.00
NeoGenomics (NEO) United States $1.478B 0.00
Trevi Therapeutics (TRVI) United States $1.470B 0.00
Intellia Therapeutics (NTLA) United States $1.422B 0.00
Upstream Bio (UPB) United States $1.416B 0.00
AnaptysBio (ANAB) United States $1.377B 0.00
AtaiBeckley Inc (ATAI) Netherlands $1.369B 0.00
Fortrea Holdings (FTRE) United States $1.354B 28.73
Novavax (NVAX) United States $1.341B 3.41
Nurix Therapeutics (NRIX) United States $1.295B 0.00
Rapport Therapeutics (RAPP) United States $1.291B 0.00
Monte Rosa Therapeutics (GLUE) United States $1.273B 61.09
Biohaven (BHVN) United States $1.228B 0.00
Kodiak Sciences (KOD) United States $1.222B 0.00
Inhibrx Biosciences (INBX) United States $1.220B 0.00
Oxford BioMedica (OXBDF) United Kingdom $1.186B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.172B 0.00
Immatics (IMTX) Germany $1.171B 0.00
Zenas BioPharma (ZBIO) United States $1.170B 0.00
Compass Therapeutics (CMPX) United States $1.160B 0.00
Certara (CERT) United States $1.152B 21.26
Septerna (SEPN) United States $1.138B 0.00
NovoCure (NVCR) Jersey $1.136B 0.00
Pharming Group (PHAR) Netherlands $1.129B 0.00
EyePoint (EYPT) United States $1.101B 0.00
Sana Biotechnology (SANA) United States $1.047B 0.00
Oric Pharmaceuticals (ORIC) United States $1.015B 0.00
Nanobiotix S.A - (NBTX) France $1.009B 0.00
Iovance Biotherapeutics (IOVA) United States $1.004B 0.00
Ventyx Biosciences (VTYX) United States $1.002B 0.00
Vir Biotechnology (VIR) United States $1.000B 0.00
Urogen Pharma (URGN) United States $0.999B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $0.996B 0.00
Geron (GERN) United States $0.977B 0.00
Palvella Therapeutics (PVLA) United States $0.973B 0.00
CytomX Therapeutics (CTMX) United States $0.961B 14.18
Castle Biosciences (CSTL) United States $0.956B 131.00
AbCellera Biologics (ABCL) Canada $0.946B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.935B 0.00
CureVac (CVAC) Germany $0.927B 0.00
Pacira BioSciences (PCRX) United States $0.903B 10.34
ArriVent BioPharma (AVBP) United States $0.902B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.898B 0.00
Arvinas (ARVN) United States $0.866B 0.00
Inventiva S.A (IVA) France $0.858B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.856B 0.00
DBV Technologies S.A (DBVT) France $0.854B 0.00
Bicara Therapeutics (BCAX) United States $0.841B 0.00
YD Bio (YDES) $0.795B 0.00
GH Research (GHRS) Ireland $0.789B 0.00
Janux Therapeutics (JANX) United States $0.786B 0.00
MapLight Therapeutics (MPLT) United States $0.770B 0.00
MiMedx (MDXG) United States $0.763B 13.55
Gyre Therapeutics (GYRE) United States $0.759B 98.50
Jade Biosciences (JBIO) United States $0.755B 0.00
BioAge Labs (BIOA) United States $0.743B 0.00
Bright Minds Biosciences (DRUG) United States $0.739B 0.00
Arbutus Biopharma (ABUS) United States $0.739B 0.00
Cullinan Therapeutics (CGEM) United States $0.723B 0.00
Astria Therapeutics (ATXS) United States $0.718B 0.00
Annexon (ANNX) United States $0.686B 0.00
Kura Oncology (KURA) United States $0.681B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Prime Medicine (PRME) United States $0.644B 0.00
Replimune (REPL) United States $0.640B 0.00
EnGene Holdings (ENGN) Canada $0.640B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.612B 0.00
CorMedix Inc (CRMD) United States $0.606B 5.61
LB Pharmaceuticals Inc (LBRX) United States $0.603B 0.00
MeiraGTx Holdings (MGTX) United States $0.598B 0.00
Design Therapeutics (DSGN) United States $0.585B 0.00
Emergent Biosolutions (EBS) United States $0.574B 5.52
Cytek Biosciences (CTKB) United States $0.572B 0.00
Evommune (EVMN) United States $0.546B 0.00
Keros Therapeutics (KROS) United States $0.535B 11.41
SELLAS Life Sciences (SLS) United States $0.531B 0.00
Fulcrum Therapeutics (FULC) United States $0.527B 0.00
Gossamer Bio (GOSS) United States $0.523B 0.00
REGENXBIO (RGNX) United States $0.523B 0.00
Solid Biosciences (SLDB) United States $0.508B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.497B 0.00
Prothena (PRTA) Ireland $0.480B 0.00
Myriad Genetics (MYGN) United States $0.477B 0.00
Alto Neuroscience (ANRO) United States $0.473B 0.00
Kamada (KMDA) Israel $0.472B 22.81
Tectonic Therapeutic (TECX) United States $0.456B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.447B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.447B 0.00
Verastem (VSTM) United States $0.445B 0.00
LENZ Therapeutics (LENZ) United States $0.445B 0.00
Contineum Therapeutics (CTNM) United States $0.438B 0.00
PureTech Health (PRTC) United States $0.437B 0.00
NovaBridge Biosciences (NBP) United States $0.427B 0.00
DiaMedica Therapeutics (DMAC) United States $0.424B 0.00
Ocugen (OCGN) United States $0.415B 0.00
Benitec Biopharma (BNTC) United States $0.415B 0.00
Niagen Bioscience (NAGE) United States $0.415B 32.50
Northwest Biotherapeutics (NWBO) United States $0.406B 0.00
Absci (ABSI) United States $0.405B 0.00
Entrada Therapeutics (TRDA) United States $0.405B 0.00
Greenwich LifeSciences (GLSI) United States $0.402B 0.00
Eton Pharmaceuticals (ETON) United States $0.396B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.393B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.392B 0.00
Zura Bio (ZURA) United States $0.391B 0.00
Prima BioMed (IMMP) Australia $0.386B 0.00
Monopar Therapeutics (MNPR) United States $0.386B 0.00
Allogene Therapeutics (ALLO) United States $0.380B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.378B 0.00
Climb Bio (CLYM) United States $0.371B 0.00
Invivyd (IVVD) United States $0.371B 0.00
Adlai Nortye (ANL) Cayman Islands $0.369B 0.00
Anavex Life Sciences (AVXL) United States $0.366B 0.00
GENFIT S.A (GNFTY) France $0.361B 0.00
Immix Biopharma (IMMX) United States $0.357B 0.00
Aura Biosciences (AURA) United States $0.356B 0.00
Neumora Therapeutics (NMRA) United States $0.354B 0.00
Puma Biotechnology (PBYI) United States $0.350B 9.38
Kyverna Therapeutics (KYTX) United States $0.347B 0.00
Forte Biosciences (FBRX) United States $0.346B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.342B 0.00
Atea Pharmaceuticals (AVIR) United States $0.324B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.324B 0.00
Foghorn Therapeutics (FHTX) United States $0.321B 0.00
Candel Therapeutics (CADL) United States $0.320B 0.00
Immuneering (IMRX) United States $0.318B 0.00
AC Immune (ACIU) Switzerland $0.315B 0.00
X4 Pharmaceuticals (XFOR) United States $0.311B 0.00
PepGen (PEPG) United States $0.308B 0.00
XOMA Royalty (XOMA) United States $0.308B 0.00
Amarin (AMRN) Ireland $0.307B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.300B 0.00
Rezolute (RZLT) United States $0.289B 0.00
Lifecore Biomedical (LFCR) United States $0.284B 0.00
Abeona Therapeutics (ABEO) United States $0.278B 4.54
Aardvark Therapeutics (AARD) United States $0.275B 0.00
Adherex Technologies (FENC) United States $0.268B 0.00
Neurogene (NGNE) United States $0.267B 0.00
Coherus Oncology (CHRS) United States $0.259B 0.00
Nautilus Biotechnology (NAUT) United States $0.256B 0.00
Palisade Bio (PALI) United States $0.244B 0.00
Cabaletta Bio (CABA) United States $0.242B 0.00
Shattuck Labs (STTK) United States $0.239B 0.00
Adocia (ADOCY) France $0.231B 0.00
Nuvectis Pharma (NVCT) United States $0.228B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.221B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.215B 0.00
Alector (ALEC) United States $0.214B 0.00
Opus Genetics (IRD) United States $0.208B 0.00
Voyager Therapeutics (VYGR) United States $0.205B 0.00
SAB Biotherapeutics (SABS) United States $0.199B 0.00
Molecular Partners AG (MOLN) Switzerland $0.190B 0.00
Sagimet Biosciences (SGMT) United States $0.181B 0.00
CAMP4 Therapeutics (CAMP) United States $0.180B 0.00
Editas Medicine (EDIT) United States $0.178B 0.00
C4 Therapeutics (CCCC) United States $0.176B 0.00
Humacyte (HUMA) United States $0.176B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.173B 0.00
Cartesian Therapeutics (RNAC) United States $0.169B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.162B 0.00
Innate Pharma S.A (IPHA) France $0.160B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.158B 0.00
Tharimmune (THAR) United States $0.156B 0.00
Kalaris Therapeutics (KLRS) United States $0.156B 0.00
Alps Group (ALPS) United States $0.155B 2.82
Anika Therapeutics (ANIK) United States $0.151B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.150B 0.00
Rani Therapeutics Holdings (RANI) United States $0.148B 0.00
Caribou Biosciences (CRBU) United States $0.147B 0.00
Elicio Therapeutics (ELTX) United States $0.146B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.145B 0.00
Mersana Therapeutics (MRSN) United States $0.145B 0.00
Nkarta (NKTX) United States $0.143B 0.00
Jyong Biotech (MENS) Taiwan $0.142B 0.00
Vor Biopharma (VOR) $0.137B 0.00
Spero Therapeutics (SPRO) United States $0.136B 0.00
Connect Biopharma Holdings (CNTB) United States $0.136B 0.00
Tenaya Therapeutics (TNYA) United States $0.135B 0.00
Sangamo Therapeutics (SGMO) United States $0.135B 0.00
Sutro Biopharma (STRO) United States $0.132B 0.00
Crescent Biopharma (CBIO) United States $0.132B 0.00
Fate Therapeutics (FATE) United States $0.132B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.131B 0.00
Whitehawk Therapeutics (WHWK) United States $0.130B 0.00
Black Diamond Therapeutics (BDTX) United States $0.128B 6.26
Seres Therapeutics (MCRB) United States $0.126B 0.00
Adagene (ADAG) China $0.124B 0.00
Alpha Teknova (TKNO) United States $0.120B 0.00
Codexis (CDXS) United States $0.120B 0.00
Starpharma Holdings (SPHRY) Australia $0.118B 0.00
VTv Therapeutics (VTVT) United States $0.114B 0.00
Repare Therapeutics (RPTX) Canada $0.114B 0.00
Ovid Therapeutics (OVID) United States $0.114B 0.00
Turn Therapeutics (TTRX) United States $0.113B 0.00
ALX Oncology Holdings (ALXO) United States $0.111B 0.00
Alpha Cognition (ACOG) Canada $0.111B 0.00
BGM Group (BGM) China $0.111B 0.00
Cardiff Oncology (CRDF) United States $0.108B 0.00
BioStem Technologies (BSEM) $0.105B 7.34
Actuate Therapeutics (ACTU) United States $0.103B 0.00
Fortress Biotech (FBIO) United States $0.101B 0.00
Coya Therapeutics (COYA) United States $0.101B 0.00
Agenus (AGEN) United States $0.100B 0.00
Seer (SEER) United States $0.100B 0.00
Citius Oncology (CTOR) United States $0.100B 0.00
Artiva Biotherapeutics (ARTV) United States $0.099B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.099B 0.00
Chrome Holding (MEHCQ) United States $0.096B 0.00
Adverum Biotechnologies (ADVM) United States $0.096B 0.00
Oncolytics Biotech (ONCY) Canada $0.094B 0.00
Cognition Therapeutics (CGTX) United States $0.094B 0.00
Equillium (EQ) United States $0.093B 0.00
Genelux (GNLX) United States $0.091B 0.00
EXoZymes (EXOZ) United States $0.088B 0.00
ATyr Pharma (ATYR) United States $0.088B 0.00
Biomea Fusion (BMEA) United States $0.086B 0.00
MaxCyte (MXCT) United States $0.086B 0.00
Tenax Therapeutics (TENX) United States $0.079B 0.00
BioHarvest Sciences (BHST) Canada $0.079B 0.00
MediciNova (MNOV) United States $0.079B 0.00
Spruce Biosciences (SPRB) United States $0.078B 0.00
ImageneBio (IMA) United States $0.077B 0.00
Immunic (IMUX) United States $0.075B 0.00
XBiotech (XBIT) United States $0.072B 0.00
OKYO Pharma (OKYO) $0.072B 0.00
Scilex Holding (SCLX) United States $0.072B 0.00
Pliant Therapeutics (PLRX) United States $0.070B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.068B 0.00
Adicet Bio (ACET) United States $0.067B 0.00
Annovis Bio (ANVS) United States $0.066B 0.00
BeyondSpring (BYSI) United States $0.061B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.060B 0.00
InflaRx (IFRX) Germany $0.060B 0.00
Radiopharm Theranostics - (RADX) Australia $0.059B 0.00
TScan Therapeutics (TCRX) United States $0.058B 0.00
Cingulate (CING) United States $0.057B 0.00
Grace Therapeutics (GRCE) United States $0.056B 0.00
Estrella Immunopharma (ESLA) United States $0.055B 0.00
Tevogen Bio Holdings (TVGN) United States $0.055B 0.00
IBio (IBIO) United States $0.054B 0.00
Instil Bio (TIL) United States $0.053B 0.00
Q32 Bio (QTTB) United States $0.052B 0.00
MiNK Therapeutics (INKT) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.050B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.050B 0.00
CervoMed (CRVO) United States $0.049B 0.00
Entera Bio (ENTX) Israel $0.048B 0.00
Clene (CLNN) United States $0.047B 0.00
Aligos Therapeutics (ALGS) United States $0.045B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
ABVC BioPharma (ABVC) United States $0.042B 0.00
Elutia (ELUT) United States $0.042B 0.00
Galecto (GLTO) Denmark $0.040B 0.00
INmune Bio (INMB) United States $0.040B 0.00
Lisata Therapeutics (LSTA) United States $0.040B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.040B 0.00
NextCure (NXTC) United States $0.039B 0.00
Jasper Therapeutics (JSPR) United States $0.038B 0.00
Celularity (CELU) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
RenovoRx (RNXT) United States $0.036B 0.00
Generation Bio (GBIO) United States $0.036B 0.00
Atara Biotherapeutics (ATRA) United States $0.035B 2.24
PDS Biotechnology (PDSB) United States $0.035B 0.00
Tvardi Therapeutics (TVRD) United States $0.035B 0.00
Pluri (PLUR) Israel $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Hyperion DeFi (HYPD) United States $0.034B 0.00
Kyntra Bio Inc (KYNB) United States $0.033B 0.00
BioXcel Therapeutics (BTAI) United States $0.033B 0.00
TELA Bio (TELA) United States $0.033B 0.00
TuHURA Biosciences (HURA) United States $0.032B 0.00
Oncobiologics (OTLK) United States $0.032B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
Dyadic (DYAI) United States $0.031B 0.00
BRIACELL THERAP (BCTX) Canada $0.030B 0.00
Passage Bio (PASG) United States $0.030B 0.00
Rein Therapeutics (RNTX) United States $0.030B 0.00
AN2 Therapeutics (ANTX) United States $0.030B 0.00
Werewolf Therapeutics (HOWL) United States $0.030B 0.00
Femasys (FEMY) United States $0.030B 0.00
Lantern Pharma (LTRN) United States $0.030B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.029B 0.00
Medicus Pharma (MDCX) United States $0.028B 0.00
Promis Neurosciences (PMN) Canada $0.027B 0.00
Athira Pharma (ATHA) United States $0.027B 0.00
Skye Bioscience (SKYE) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Exicure (XCUR) United States $0.026B 0.00
Aytu BioPharma (AYTU) United States $0.026B 0.00
Cue Biopharma (CUE) United States $0.025B 0.00
IO Biotech (IOBT) Denmark $0.025B 0.00
Rallybio (RLYB) United States $0.025B 0.00
Senti Biosciences (SNTI) United States $0.024B 0.00
Dare Bioscience (DARE) United States $0.024B 0.00
VistaGen Therapeutics (VTGN) United States $0.022B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.022B 0.00
Neuphoria Therapeutics (NEUP) United States $0.022B 0.00
Apollomics (APLM) United States $0.021B 0.00
Intensity Therapeutics (INTS) United States $0.021B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.021B 0.00
LeonaBio (LONA) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
FibroBiologics (FBLG) United States $0.017B 0.00
Pasithea Therapeutics (KTTA) United States $0.017B 0.00
Black Titan (BTTC) United States $0.016B 0.00
Quantum Biopharma (QNTM) Canada $0.016B 0.00
Applied Therapeutics (APLT) United States $0.014B 0.00
Genenta Science S.p.A (GNTA) Italy $0.014B 0.00
Polyrizon (PLRZ) Israel $0.013B 0.00
BioAtla (BCAB) United States $0.013B 0.00
Cocrystal Pharma (COCP) United States $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
Cadrenal Therapeutics (CVKD) United States $0.013B 0.00
Curis (CRIS) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
NewcelX (NCEL) Switzerland $0.013B 0.00
Hoth Therapeutics (HOTH) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Soligenix (SNGX) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Longeveron (LGVN) United States $0.011B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.011B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
IN8bio (INAB) United States $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Biofrontera (BFRI) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
Edesa Biotech (EDSA) Canada $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Beyond Air (XAIR) United States $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.009B 0.00
CalciMedica (CALC) United States $0.009B 0.00
Mainz Biomed (MYNZ) Germany $0.009B 0.00
Quince Therapeutics (QNCX) United States $0.008B 0.00
Purple Biotech (PPBT) Israel $0.008B 0.00
Gelteq (GELS) Australia $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.008B 0.00
Dogwood Therapeutics (DWTX) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Aptevo Therapeutics (APVO) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.006B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Advanced Biomed (ADVB) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Decoy Therapeutics Inc (DCOY) United States $0.005B 0.00
Aprea Therapeutics (APRE) United States $0.005B 0.00
KALA BIO (KALA) United States $0.004B 0.00
Cyclerion Therapeutics (CYCN) United States $0.004B 0.00
Abpro Holdings (ABP) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
MetaVia (MTVA) United States $0.004B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.004B 0.00
BioAffinity Technologies (BIAF) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
HCW Biologics (HCWB) United States $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Arcadia Biosciences (RKDA) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Ensysce Biosciences (ENSC) United States $0.002B 0.00
Enveric Biosciences (ENVB) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Compugen (CGEN) Israel $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00